Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
49.34 EUR | -0.72% | +2.03% | +1.04% |
Jun. 04 | Recordati continues buyback plan; nearly 64,000 shares purchased | AN |
May. 27 | Recordati acquires treasury shares for more than EUR3 million | AN |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The firm trades with high earnings multiples: 22.35 times its 2024 earnings per share.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.04% | 11.05B | A- | ||
+46.90% | 765B | C+ | ||
-5.99% | 354B | C+ | ||
+20.10% | 331B | B- | ||
+8.74% | 299B | C+ | ||
+18.91% | 248B | B+ | ||
-1.76% | 219B | A+ | ||
+11.02% | 216B | B- | ||
+5.32% | 164B | C+ | ||
-2.66% | 162B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- REC Stock
- Ratings Recordati